1. Home
  2. ELTX vs CTGO Comparison

ELTX vs CTGO Comparison

Compare ELTX & CTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • CTGO
  • Stock Information
  • Founded
  • ELTX 2011
  • CTGO 2009
  • Country
  • ELTX United States
  • CTGO United States
  • Employees
  • ELTX N/A
  • CTGO N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • CTGO Precious Metals
  • Sector
  • ELTX Health Care
  • CTGO Basic Materials
  • Exchange
  • ELTX Nasdaq
  • CTGO Nasdaq
  • Market Cap
  • ELTX 121.7M
  • CTGO 114.5M
  • IPO Year
  • ELTX N/A
  • CTGO N/A
  • Fundamental
  • Price
  • ELTX $4.95
  • CTGO $10.20
  • Analyst Decision
  • ELTX Strong Buy
  • CTGO Strong Buy
  • Analyst Count
  • ELTX 3
  • CTGO 1
  • Target Price
  • ELTX $9.50
  • CTGO $37.00
  • AVG Volume (30 Days)
  • ELTX 39.4K
  • CTGO 120.5K
  • Earning Date
  • ELTX 03-31-2025
  • CTGO 03-17-2025
  • Dividend Yield
  • ELTX N/A
  • CTGO N/A
  • EPS Growth
  • ELTX N/A
  • CTGO N/A
  • EPS
  • ELTX N/A
  • CTGO N/A
  • Revenue
  • ELTX N/A
  • CTGO N/A
  • Revenue This Year
  • ELTX N/A
  • CTGO N/A
  • Revenue Next Year
  • ELTX N/A
  • CTGO N/A
  • P/E Ratio
  • ELTX N/A
  • CTGO N/A
  • Revenue Growth
  • ELTX N/A
  • CTGO N/A
  • 52 Week Low
  • ELTX $3.34
  • CTGO $8.85
  • 52 Week High
  • ELTX $11.45
  • CTGO $25.32
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 23.49
  • CTGO 53.30
  • Support Level
  • ELTX $7.54
  • CTGO $9.57
  • Resistance Level
  • ELTX $8.13
  • CTGO $10.19
  • Average True Range (ATR)
  • ELTX 0.55
  • CTGO 0.72
  • MACD
  • ELTX -0.29
  • CTGO 0.07
  • Stochastic Oscillator
  • ELTX 1.02
  • CTGO 46.87

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About CTGO Contango ORE Inc.

Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's primary focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Tetlin Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska.

Share on Social Networks: